Needle-Free Injection Market:
Needle-Free Injection Market is projected to be worth USD 430 million by 2030, registering a CAGR of 15% during the forecast period (2022-2030), the market was valued at USD 122 million in 2021. The liquid-based sub-segment is expected to contribute the largest share to the growth of the needle-free injection market. The precise nozzle dimensions of liquid-based needle-free injections are one of the key reasons for increased needle-free injection market growth. The jet-based needle-free injections also accounted for the largest market share due to their better diffusion into the tissues. North America has one of the major share contributions to the needle-free injection market growth.
Needle-Free Injection Market Dynamics:
Needle-free injections are used to deliver vaccines or drugs by using different types of injections that do not require the penetration of needles into the skin of patients. The benefit of needle-free injections is that they easily administer thick medicine solutions into the bloodstream as compared to needles or syringes.
Driver:
The convenience of self-injection medicine devices and increased investments in the pharmaceutical industry have been the key drivers of market growth. The increased demand for self-injection devices also allows patients to get easy access to treatments for chronic diseases. Chronic diseases such as rheumatoid arthritis and cancer are one of the key areas that are predicted to drive the market growth of needle-free injections.
Restraint:
Needle-free injections are expensive as compared to traditional injections which also require separate approvals from regulatory authorities. Thus, the high development costs and lower volumes of orders for needleless injections are key restraints to the growth of the market. Additionally, manufacturers are expected to consider the challenges of sterility in needle-free injections, and expensive development costs, which are expected to hamper the growth of the needle-free injection market.
Opportunity:
The increased incidents of communicable diseases due to needle stick injuries are expected to create opportunities for the growth of the needle-free injection market. The recent COVID-19 pandemic experience led to the increased awareness of infectious diseases which led to increased demand for self-injection kits. Furthermore, pharmaceutical companies are expected to focus on the increased demand for biosimilar for the treatment of acute and chronic diseases which is expected to boost the opportunities of the market.
COVID-19 Analysis of Needle-Free Injection Market:
The COVID-19 pandemic created a favorable impact on the needle-free injection market. In 2019, the needle-free injection market grew significantly due to mass vaccinations and the high demand for self-injectable devices in many different parts of the world. The rise in Research & Development investments of market players and partnerships with government agencies contributed to the increased market share of the needle-free injection market. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the needle-free injection market is moderate. Post covid-19 there was a positive impact on the needle-free injection market as consumers were more focused on restricting communicable diseases, which increased the demand for needle-free injections.
Needle-Free Injection Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Million) | 430 million |
| CAGR (2022-2030) | 15% |
| By Type | Liquid-based, Projectile/depot-based, Powder-based |
| By Product | Fillable, Prefilled |
| By Delivery Site | Subcutaneous, Intramuscular, Intradermal |
| By Technology | Jet-Based, Spring Global, Laser-Powered, Vibration-Based |
| By Application | Vaccine Delivery, Insulin Delivery, Pain Management, Others |
| By End-Use | Hospitals & Clinics, Home Care Settings, Research Laboratories |
| By Geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | PharmaJet, Portal Instruments, Medical International Technology, Inc, PenJet Corporation, NuGen Medical Devices, Antares Pharma Inc., Crossject, and Bioject Medical Technologies |
Needle-Free Injection Market Segment Analysis:
By Type
The segment is divided into liquid-based, projectile/depot-based, and powder-based. In 2021, the liquid-based segment contributed the largest share of 75% of the needle-free injection system market. For instance, the stronger ability to penetrate the skin without causing harm to the drug molecule and the underlying layer of skin are the key factors that fuel the increased contribution of the liquid-based segment in the needle-free injection market. Further, the powder-based needle-free injection contains variations such as multiple nozzles in different shapes and depth diameters. Thus, the projectile, and powdered-base segments, are expected to support the increased needle-free injection market in the forecast period.
By Product
The product segment is bifurcated into fillable and prefilled sub-segments. The fillable segment dominated the product segment with the largest market share. The wide applicability of fillable needle-free injections in drug administration, vaccination, and other types of drug delivery is one of the key reasons for the dominance of this segment. Furthermore, fillable needle-free injectors have benefits such as less wastage as compared to prefilled injectors, which is driving the growth of the fillable segment in the needle-free injection market.
By technology
The needleless injections are segmented as jet-based, spring global, laser-powered, and vibration-based. In 2020, the jet-based segment is expected to account for the largest share of 70% of the global needle-free injection market. The key contributing factors are improved dosage accuracy and faster response rate that led to the dominance of this segment in the market. Additionally, the jet-based segment has better drug delivery with a high-speed stream of fluids over spring global, laser-powered, and vibration-based segments. The segments such as laser-powered, vibration-based, and spring global are also expected to share the increased contribution to the growth of the needle-free injection market.
By End-Use
The end-user segment is divided into sub-segments like hospitals & clinics, home care settings, and research laboratories. The hospitals & clinics segment is expected to gain a larger market share in the needle-free injection market. The factors contributing to the increased market share of the hospitals & clinics segment are enhanced technological developments, high demand for vaccination and fast resolution of infection risks associated with injection site. Furthermore, the home care settings segment is also estimated to support the growth of needle-free injection market. Owing to the convenience of patients and increased demand for self-injection kits.
By Delivery Site
The market is divided into subcutaneous, intramuscular, and intradermal. The subcutaneous injections sub-segment has gained the largest share in the global needle-free injection market. Subcutaneous injectors are majorly used for drug administrations that require slow and steady absorption into the bloodstream for treatment diseases such as diabetes, cardiovascular diseases and severe allergic diseases. Hence, the subcutaneous injections with formulations such as insulin, epinephrine, heparin, and allergy medication are expected to support the increased contribution of the subcutaneous segment. Moreover, subcutaneous drug delivery is one of the effective methods that boost the immune response at faster rates due to its ability to reach the skin area rich in immune cells. Hence, the growing usage of subcutaneous injectors is expected to drive the growth of the needle-free injection market.
By Application:
Based on application, the segment is divided into vaccine delivery, pain management, insulin delivery, and others. The vaccine delivery segment has the major share contribution to the increased needle-free injection market growth. Due to the stronger and longer immune response in terms of mass immunization. Furthermore, the insulin delivery segment is expected to have an increased market share in the forecast period due to the rise in the number of diabetic patients around the world. However, insulin delivery, pain management, and other segments are also expected to drive the growth of the needle-free injection market.
By Region
The regional segment includes Europe, Asia Pacific, Middle East, North America, and Africa, Latin America. In 2021, North America led the growth of the market with the greatest revenue share of 58%, owing to the existence of key companies and the growing incidence rate of targeted illnesses in the area. on the basis of region, the needle-free injection market is further led by Europe and the Asia-Pacific (APAC). However, in Asia-Pacific, China led the regional market. Owing to the increased number of aged populations, favorable government initiatives and rising per capita income are supporting the needle-free injection market growth in the APAC regions.
Needle-Free Injection Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and technology launches have accelerated the growth of the needle-free medicine market. Key players in the market include-
- PharmaJet
- Medical International Technology, Inc
- NuGen Medical Devices
- Portal Instruments
- PenJet Corporation
- Antares Pharma Inc., Crossject SA
- Bioject Medical Technologies
Recent Development:
- In December 2021, the partnering firm of PharmaJet named Nykode Therapeutic announced two-phased clinical trials of DNA-based COVID-19 vaccines to the trial candidates. These vaccines are delivered intradermally using needle-free injections to the area under skin layers that is rich in immune cells.
- In 2021, Enesi Pharma has developed thermostable solid-dose live vaccines against diseases such as Rubella and Measles. These vaccines deliver a specific dosage of the formulation to reduce the cross contaminations during drug administration.
In August 2021, one of the divisions of PharmaJet named Zydus Cadila received the Emergency Use Authorization approval for delivering DNA COVID-19 vaccines using needle-free injections.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Needle-free injection market
- Global Needle-Free Injection Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Needle-Free Injection Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Needle-free injection market demand
- Post-Covid Impact on Needle-Free Injection Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Needle-Free Injection Market Segmentation, by Volume (Unit) & Revenue (USD Billion), (2022-2030)
- By Type
- Liquid-based
- Projectile/depot-based
- Powder-based
- By Product
- Fillable
- Prefilled
- By Delivery Site
- Subcutaneous
- Intramuscular
- Intradermal
- By Technology
- Jet-Based
- Spring Global
- Laser-Powered
- Vibration-Based
- By Application
- Vaccine Delivery
- Insulin Delivery
- Pain Management
- Others
- By End Use
- Hospitals & Clinics
- Home Care Settings
- Research Laboratories
- By Type
- Global Needle-Free Injection Market Overview, By Region
- North America Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Type
- By Product
- By Delivery Site
- By Technology
- By Application
- By End Use
- Canada
- Mexico
- US
- Europe Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Needle-Free Injection Market Volume (Unit) & Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Needle-Free Injection Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- PharmaJet
- Business Overview
- Business Financials (USD Million)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Portal Instruments
- Medical International Technology, Inc
- PenJet Corporation
- NuGen Medical Devices
- Antares Pharma Inc.
- Crossject
- Bioject Medical Technologies
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.